Cargando…
Drug‐Induced Liver Injury in GI Practice
Although drug‐induced liver injury (DILI) is a rare clinical event, it carries significant morbidity and mortality, leaving it as the leading cause of acute liver failure in the United States. It is one of the most challenging diagnoses encountered by gastroenterologists. The development of various...
Autores principales: | Sandhu, Naemat, Navarro, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193133/ https://www.ncbi.nlm.nih.gov/pubmed/32363315 http://dx.doi.org/10.1002/hep4.1503 |
Ejemplares similares
-
Endoscopic electrocautery incision therapy for benign lower gastrointestinal tract anastomotic strictures
por: Jain, Deepanshu, et al.
Publicado: (2017) -
Adverse drug reactions in the differential diagnosis of GI and liver diseases
Publicado: (1989) -
Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
por: Sloan, Joshua, et al.
Publicado: (2016) -
Plummer-Vinson syndrome: improving outcomes with a multidisciplinary approach
por: Lo, Kevin Bryan, et al.
Publicado: (2019) -
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
por: Fontana, Robert J., et al.
Publicado: (2023)